Synbiobeta is a unique event which exemplifies the optimism and enthusiasm our industry has for building a better more sustainable world.
San Francisco, California (PRWEB)
September 27, 2017
TeselaGen founder and CEO Mike Fero has been selected to speak at SynBioBeta SF 2017, the annual conference bringing together entrepreneurs, investors, and practitioners to drive the synthetic biology industry forward. Other speakers at the industry’s premier event include genetics pioneer George Church, computing entrepreneur and venture capitalist Vinod Khosla and one of the founders of synthetic biology, James Collins.
“We couldn’t be more excited for this year’s conference, which comes at a crucial moment for the synthetic biology industry as a whole,” said SynBioBeta founder and CEO John Cumbers. “In just the last ten years, the pace of innovation has increased dramatically, and the impact of biotechnology is beginning to be felt in all industries. At SynBioBeta SF 2017, we will take stock of where we are today, and explore the various ways synthetic biology will shape the future.”
Key themes at the SynBioBeta conference this year include biomaterials and consumer products, cell factories for biopharmaceuticals, big data and artificial intelligence meet biology, and innovations for ocean sustainability. Talks and panels will discuss the future of DNA synthesis, why protein is the killer app, investment opportunities throughout the industry and why all companies need to be thinking about a Bio-Strategy in order to be able to compete.
Dr. Michael Fero, Chief Executive Officer, TeselaGen, said, “TeselaGen has a laser-like focus on building scalable enterprise quality software so badly needed by this new industry. We have had a lot of recent quantifiable success helping our Industrial and AgTech customers, so it is great to be able to share our story with our friends and colleagues. Synbiobeta is a unique event which exemplifies the optimism and enthusiasm our industry has for building a better more sustainable world.”
TeselaGen has built a secure scalable enterprise quality software platform for synthetic biology, accelerating the development of medicines, improved crops, and sustainably sourced chemicals and…